相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。1,3-β-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia
Laurence Senn et al.
CLINICAL INFECTIOUS DISEASES (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Administration of micafungin as prophylactic antifungal therapy in patients undergoing allogeneic stem cell transplantation
Satoshi Hashino et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2008)
Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: Systematic review and meta-analysis
Eyal Robenshtok et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Caspofungin as primary antifungal prophylaxis in stem cell transplant recipients
Lillian S. Chou et al.
PHARMACOTHERAPY (2007)
A double-blind trial on prophylactic voriconazole (VRC) or placebo during induction chemotherapy for acute myelogenous leukaemia (AML)
Joerg J. Vehreschild et al.
JOURNAL OF INFECTION (2007)
Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia
Oliver A. Cornely et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies
Johan Maertens
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Micafungin: A new echinocandin
PH Chandrasekar et al.
CLINICAL INFECTIOUS DISEASES (2006)
Pharmacokinetic and maximum tolerated dose study of micafungin in combination with fluconazole versus fluconazole alone for prophylaxis of fungal infections in adult patients undergoing a bone marrow or peripheral stem cell transplant
J Hiemenz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies
A Glasmacher et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation
JAH van Burik et al.
CLINICAL INFECTIOUS DISEASES (2004)
Prospective comparison of the diagnostic potential of real-time PCR, double-sandwich enzyme-linked Immunosorbent assay for galactomannan, and a (1→3)-β-D-glucan test in weekly screening for invasive aspergillosis in patients with hematological disorders
M Kawazu et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Vancomycin versus placebo for treating persistent fever in patients with neutropenic cancer receiving piperacillin-tazobactam monotherapy
A Cometta et al.
CLINICAL INFECTIOUS DISEASES (2003)
In vitro activity of FK463, a novel lipopeptide antifungal agent, against a variety of clinically important molds
T Nakai et al.
CHEMOTHERAPY (2002)
Voriconazole - In the treatment of invasive aspergillosis
RBR Muijsers et al.
DRUGS (2002)
Towards a targeted, risk-based, antifungal strategy in neutropenic patients
HG Prentice et al.
BRITISH JOURNAL OF HAEMATOLOGY (2000)
In vitro activities of a new lipopeptide antifungal agent, FK463, against a variety of clinically important fungi
S Tawara et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
分享论文
